VERTEX PHARMACEUTICALS INC / MA (VRTX)
Clinical trial NCT06619860 updates: 1. completion date: 2026-05-30 → 2027-04-22 2. primary completion date: 2026-04-30 → 2027-03-25
Clinical trial NCT06619860 updates: 1. completion date: 2026-05-30 → 2027-04-22 2. primary completion date: 2026-04-30 → 2027-03-25
📉 **NEGATIVE** • Medium confidence analysis (65%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (23%) **Content type:** Clinical